Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Maruta

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 1, 1995
[Hypoplastic leukemia achieved long-term remission with low-dose cytosine arabinoside]S Fujisawa, H Kanamori, T Noguchi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 1995
[Treatment for elderly patients with acute non-lymphocytic leukemia]S Fujisawa, A Maruta, K Ogawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 1987
[Study on cell kinetics using flow cytometry--analysis of the proliferative phase in acute leukemia]H Kanamori, A Maruta, K Takahashi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 1, 1989
[Allogeneic bone marrow transplantation as primary treatment in acute myelofibrosis]A Maruta, M Matsuzaki, H Kanamori, et al.
The Journal of Laboratory and Clinical Medicine|December 1, 1992
Endogenous urinary 3-hydroxyproline has 96% specificity and 44% sensitivity for cancer screeningI Okazaki, S Matsuyama, F Suzuki, et al.
American Journal of Hematology|January 1, 1992
Low-dose cytosine arabinoside for treating hypocellular acute leukemia in the elderlyH Kanamori, A Maruta, H Miyashita, et al.
The American Journal of the Medical Sciences|February 1, 1992
Case report: fulminant hepatitis C viral infection after allogeneic bone marrow transplantationH Kanamori, H Fukawa, A Maruta, et al.
American Journal of Hematology|November 1, 1985
B-prolymphocytic leukemia cells that form rosettes with sheep red blood cells through monoclonal surface immunoglobulinA Maruta, S Motomura, K Ogawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 3, 2001
[Sequential analysis of p210- and p190-bcr-abl by RT-PCR after allogeneic bone marrow transplantation for p210/p190-bcr-abl double positive acute lymphoblastic leukemia]K Fujimaki, A Maruta, M Yoshida, et al.
Bone Marrow Transplantation|April 6, 2004
Thiotepa/cyclophosphamide/TBI as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromeK Fujimaki, J Taguchi, H Fujita, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 1, 1995
[Hypoplastic leukemia achieved long-term remission with low-dose cytosine arabinoside]S Fujisawa, H Kanamori, T Noguchi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 1995
[Treatment for elderly patients with acute non-lymphocytic leukemia]S Fujisawa, A Maruta, K Ogawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 1987
[Study on cell kinetics using flow cytometry--analysis of the proliferative phase in acute leukemia]H Kanamori, A Maruta, K Takahashi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 1, 1989
[Allogeneic bone marrow transplantation as primary treatment in acute myelofibrosis]A Maruta, M Matsuzaki, H Kanamori, et al.
The Journal of Laboratory and Clinical Medicine|December 1, 1992
Endogenous urinary 3-hydroxyproline has 96% specificity and 44% sensitivity for cancer screeningI Okazaki, S Matsuyama, F Suzuki, et al.
American Journal of Hematology|January 1, 1992
Low-dose cytosine arabinoside for treating hypocellular acute leukemia in the elderlyH Kanamori, A Maruta, H Miyashita, et al.
The American Journal of the Medical Sciences|February 1, 1992
Case report: fulminant hepatitis C viral infection after allogeneic bone marrow transplantationH Kanamori, H Fukawa, A Maruta, et al.
American Journal of Hematology|November 1, 1985
B-prolymphocytic leukemia cells that form rosettes with sheep red blood cells through monoclonal surface immunoglobulinA Maruta, S Motomura, K Ogawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 3, 2001
[Sequential analysis of p210- and p190-bcr-abl by RT-PCR after allogeneic bone marrow transplantation for p210/p190-bcr-abl double positive acute lymphoblastic leukemia]K Fujimaki, A Maruta, M Yoshida, et al.
Bone Marrow Transplantation|April 6, 2004
Thiotepa/cyclophosphamide/TBI as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromeK Fujimaki, J Taguchi, H Fujita, et al.
Pageof 10